By Ria Kakkad (Drug Target Review)2023-01-04T11:19:38
Combining AI with cutting-edge flow cytometry and massive sequencing technologies, researchers describe CAR T cell characteristics that determine their therapeutic capacity for the first time.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-03-08T16:29:20
Sponsored by Bio-Techne
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-09-27T13:56:39
Sponsored by Euretos
2025-04-22T14:58:00
Sponsored by Takara Bio USA
Site powered by Webvision Cloud